Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2026-03-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report March 2025 7 pages 431.3KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX Market Announcement titled 'Appendix 4C and Quarterly Activities Report – March 2025' for Genetic Technologies Limited. It includes detailed quarterly cash flow statements, financial and cash flow overview, and compliance statements. The document covers the quarter ended 31 March 2025 and contains substantive financial data including cash flows from operating, investing, and financing activities, as well as notes on related party payments and financing facilities. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for ASX-listed entities, and the detailed financial data confirm this is a quarterly financial report. The document is over 14,000 characters, indicating it is a full report rather than a brief announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-03-29 English
Quarterly Activities/Appendix 4C Cash Flow Report June 2025 6 pages 413.3KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX Market Announcement titled 'Appendix 4C and Quarterly Activities Report – June 2025' for Genetic Technologies Limited. It includes detailed quarterly cash flow statements, a financial and cashflow overview, and compliance statements. The document references the quarter ended 30 June 2025 and contains substantive financial data including cash flows from operating, investing, and financing activities, as well as related party payments disclosures. The presence of the Appendix 4C quarterly cash flow report and detailed financial data for a quarter indicates this is a quarterly financial report. The document length is over 12,000 characters, so it is not a mere announcement of a report but the report itself. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-03-29 English
Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025 6 pages 426.4KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX Market Announcement containing an Appendix 4C and Quarterly Activities Report for the quarter ended 30 September 2025. It includes detailed quarterly cash flow statements, financial and cash flow overview, related party payments disclosure, and compliance statements. The document is approximately 12,547 characters long, which is substantial and contains actual financial data and analysis for a quarterly period. The presence of the Appendix 4C, which is a standard quarterly cash flow report required by ASX Listing Rule 4.7B, confirms this is a quarterly financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-03-29 English
Final Director's Interest Notice - Steven Nicols 2 pages 201.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including holdings and cessation of directorship. The content focuses on personal share transactions and interests of a company director rather than financial results, management changes, or other corporate filings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is short and specific to director interests, confirming it is not a general regulatory filing or other report type.
2026-03-26 English
Final Director's Interest Notice - William Musgrave 2 pages 200.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's cessation date and discloses the director's relevant interests in securities and contracts, with no securities held. This is a formal notification of a director's personal share transactions or interests, consistent with insider trading or director dealings disclosures. The document length is short and focused solely on director interests, with no financial results or company performance data. Therefore, it fits the category of Director's Dealing (DIRS).
2026-03-26 English
Initial Director's Interest Notice - Jeffrey Le Compte 2 pages 332.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held. This is a report of personal share transactions or interests by a company director. The document length is short and focused solely on director's interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2026-03-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.